http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110464868-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-04 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-0015 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-00 |
| filingDate | 2019-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110464868-B |
| titleOfInvention | Silicate clay modified hemostatic material and preparation method thereof |
| abstract | The invention provides a silicate clay modified hemostatic material and a preparation method thereof, wherein the hemostatic material is formed by compounding silicate clay and high polymer through electrostatic spinning; the mass ratio of the silicate clay to the high polymer is 0.5-2.5: 1; the silicate clay comprises kaolinite, halloysite, attapulgite or montmorillonite; wherein, part of silicon hydroxyl of the silicate clay is combined with the hydrogen bond of the high polymer, and the rest silicon hydroxyl plays the roles of hemostasis and hydrophily on the surface of the hemostatic material. The method comprises the following steps: firstly, carrying out pretreatment and ultrasonic crushing on silicate clay, then mixing with a high polymer ethanol solution to obtain an electrostatic spinning solution, and finally carrying out electrostatic spinning to obtain the silicate clay modified hemostatic material. The obtained hemostatic material has the advantages of high hemostatic speed, convenient use, favorable wound healing, good biocompatibility, low cost and the like. |
| priorityDate | 2019-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.